2021年真菌感染血清学诊断:从侵袭性到慢性
本文综述了2021年真菌抗原与血清学检测在侵袭性和慢性真菌感染诊断中的进展,聚焦曲霉、念珠菌和隐球菌。抗原检测如半乳甘露聚糖和β-d-葡聚糖常用但性能受人群、标本和阈值影响;床旁隐球菌抗原检测表现优异。仅少数检测可用于疗效监测,抗体检测变异性大。
要点
- 支气管肺泡灌洗液GM诊断侵袭性肺曲霉病优于血清GM,但cut-off≥1时特异性欠佳。
- 床旁隐球菌抗原检测性能优异,适用于隐球菌感染诊断。
- 血清β-d-葡聚糖在非中性粒细胞减少患者中特异性不理想。
核心结论
- 现有真菌抗原检测对侵袭性真菌感染具有优异至合理的临床性能,但仅少数可用于疗效监测。
研究设计与样本
- 综述,检索PubMed 2017至2020年发表的关于真菌抗原检测和血清学诊断侵袭性及慢性真菌感染的相关文献。
主要发现
- 支气管肺泡灌洗液GM诊断侵袭性肺曲霉病的性能优于血清GM。
- 支气管肺泡灌洗液GM以cut-off≥1时特异性不理想。
- 血清β-d-葡聚糖在非中性粒细胞减少个体中特异性欠佳。
- 床旁隐球菌抗原检测性能优异。
关键数值与推荐
- GM和β-d-葡聚糖检测的敏感性和特异性因患者人群、标本类型、定义阈值、检测策略及真菌病例定义而异。
- 多种烟曲霉IgG抗体检测市售,滴度差异大且性能显著不同。
临床怎么用
- 非培养技术推荐与常规显微镜检查和培养联合使用以提高诊断阳性率。
- 选择抗原检测时需考虑患者人群、标本类型和阈值定义对性能的影响。
- 床旁隐球菌抗原检测可用于隐球菌感染的诊断。
局限性
- 诊断检测易受宿主、微生物和实验室设置影响。
- 评估人群存在广泛异质性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Diagnosing invasive or chronic fungal infections is a challenge, particularly in the immunocompromised host. Microscopy and culture remain the reference standard, but are insensitive. The use of non-culture-based techniques is recommended in conjunction with conventional methods to improve the diagnostic yield. OBJECTIVES: The aim was to provide an updated 2021 inventory of fungal antigen and serology tests for diagnosing invasive and chronic fungal infections, the key focus was set on Aspergillus, Candida and Cryptococcus species. SOURCES: Pubmed search for publications with the key words fungal antigen tests, laboratory-based diagnosis of invasive pulmonary aspergillosis, chronic pulmonary aspergillosis, invasive candidiasis, invasive fungal infections and cryptococcal infections published from 2017 to 2020. CONTENT: Antigen assays such as the galactomannan (GM) and β-d-glucan detection systems are frequently used, but these tests vary in sensitivity and specificity, depending on the patient population involved, specimens inspected, cut-offs defined, test strategy applied and inclusion or exclusion of possible fungal case definitions. Multiple different detection systems are available, with recently introduced new point-of-care tests such as the lateral flow device and the lateral flow assay. Despite a wide heterogeneity in populations evaluated, studies indicate a better diagnostic performance of bronchoalveolar lavage GM in comparison with serum GM, and a suboptimal specificity of GM bronchoalveolar lavages (cut-off ≥1) and serum β-d-glucan in non-neutropenic individuals. Point-of-care cryptococcal antigen tests show excellent performance. IMPLICATIONS: There are fungal antigen detection tests available with excellent to reasonable clinical performance to diagnose invasive fungal infections. Only a few assays are useful to monitor therapeutic response. There are multiple marketed IgG antibody tests to detect Aspergillus fumigatus antibodies, the titres vary widely and the performance differs significantly. In general, diagnostic tests are vulnerable to being affected by the host, the microbe and laboratory setting.
引用
- Lass-Flörl C, Samardzic E, Knoll M, et al. Serology anno 2021-fungal infections: from invasive to chronic. Clin Microbiol Infect. 2021. PMID: 33601011. doi:10.1016/j.cmi.2021.02.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。